{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:11:46Z","timestamp":1790863906044,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1053\/j.ajkd.2008.11.029","type":"journal-article","created":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T04:08:33Z","timestamp":1236917313000},"page":"S3-S10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"S4","title":["Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)"],"prefix":"10.1053","volume":"53","author":[{"given":"Rohit","family":"Bhuriya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2008.11.029_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2008.11.029_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.11.029_bib3","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/ndt\/gfh813","article-title":"Chronic kidney disease as cause of cardiovascular morbidity and mortality","volume":"20","author":"Vanholder","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.11.029_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.11.029_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.11.029_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: A historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.11.029_bib7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.11.029_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.hjr.0000114706.27531.01","article-title":"Serum parathyroid hormone levels predict coronary heart disease: The Tromso Study","volume":"11","author":"Kamycheva","year":"2004","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1053\/j.ajkd.2008.11.029_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.11.029_bib10","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1210\/endo.137.10.8828488","article-title":"Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat","volume":"137","author":"Usdin","year":"1996","journal-title":"Endocrinology"},{"key":"10.1053\/j.ajkd.2008.11.029_bib11","first-page":"55","article-title":"PTH, chronic renal failure and myocardium","volume":"21","author":"Smogorzewski","year":"1995","journal-title":"Miner Electrolyte Metab"},{"key":"10.1053\/j.ajkd.2008.11.029_bib12","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1210\/endo.136.7.7789328","article-title":"The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein","volume":"136","author":"Ogino","year":"1995","journal-title":"Endocrinology"},{"key":"10.1053\/j.ajkd.2008.11.029_bib13","first-page":"H1739","article-title":"Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes","volume":"263","author":"Schluter","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1053\/j.ajkd.2008.11.029_bib14","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","article-title":"A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.11.029_bib15","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.ehj.2003.09.010","article-title":"Parathyroid hormone and left ventricular hypertrophy","volume":"24","author":"Saleh","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1053\/j.ajkd.2008.11.029_bib16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ki.1990.58","article-title":"Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure","volume":"37","author":"Akmal","year":"1990","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.11.029_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1523-1755.1998.00786.x","article-title":"Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure","volume":"53","author":"Liang","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.11.029_bib18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI111765","article-title":"Role of parathyroid hormone in the glucose intolerance of chronic renal failure","volume":"75","author":"Akmal","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2008.11.029_bib19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1172\/JCI114979","article-title":"On the mechanism of impaired insulin secretion in chronic renal failure","volume":"87","author":"Fadda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.ajkd.2008.11.029_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-2007-979898","article-title":"Endothelium is a target organ of parathyroid secretions in genetic hypertensive rats","volume":"27","author":"Schleiffer","year":"1995","journal-title":"Horm Metab Res"},{"key":"10.1053\/j.ajkd.2008.11.029_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.HYP.30.5.1284","article-title":"Increased expression of parathyroid hormone-related peptide gene in blood vessels of spontaneously hypertensive rats","volume":"30","author":"Noda","year":"1997","journal-title":"Hypertension"},{"key":"10.1053\/j.ajkd.2008.11.029_bib22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/ki.1994.182","article-title":"Studies of the vessel wall properties in hemodialysis patients","volume":"45","author":"Barenbrock","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.11.029_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0002-9343(88)80237-7","article-title":"Myocardial calcification and cardiac dysfunction in chronic renal failure","volume":"85","author":"Rostand","year":"1988","journal-title":"Am J Med"},{"key":"10.1053\/j.ajkd.2008.11.029_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00365597909181172","article-title":"Uraemic arterial disease","volume":"13","author":"Ejerblad","year":"2008","journal-title":"Scand J Urol Nephrol"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2008.11.029_bib25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/j.ajkd.2007.12.022","article-title":"The Kidney Early Evaluation Program (KEEP): Program design and demographic characteristics of the population","volume":"51","author":"Jurkovitz","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.11.029_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2008.11.029_bib27","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1053\/j.ajkd.2008.01.001","article-title":"Standardization of serum creatinine and estimated glomerular filtration rate in the National Kidney Foundation Kidney Early Evaluation Program (KEEP)","volume":"51","author":"Stevens","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.11.029_bib28","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/archinte.167.11.1122","article-title":"Independent components of chronic kidney disease as a cardiovascular risk state: Results from the Kidney Early Evaluation Program (KEEP)","volume":"167","author":"McCullough","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2008.11.029_bib29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","article-title":"25-Hydroxyvitamin D and risk of myocardial infarction in men: A prospective study","volume":"168","author":"Giovannucci","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2008.11.029_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.ki.5000045","article-title":"Vitamin D in chronic kidney disease: A systemic role for selective vitamin D receptor activation","volume":"69","author":"Andress","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.11.029_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/CIRCULATIONAHA.107.706127","article-title":"Vitamin D deficiency and risk of cardiovascular disease","volume":"117","author":"Wang","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.ajkd.2008.11.029_bib32","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.167.11.1159","article-title":"Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey","volume":"167","author":"Martins","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.ajkd.2008.11.029_bib33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1053\/j.ajkd.2008.01.017","article-title":"Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: A cross-sectional study","volume":"51","author":"Joly","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.11.029_bib34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.ki.5001606","article-title":"Inter-method variability in PTH measurement: Implication for the care of CKD patients","volume":"70","author":"Souberbielle","year":"2006","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638609000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638609000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:52:21Z","timestamp":1759456341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638609000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0272638609000250"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.029","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma Parathyroid Hormone Level and Prevalent Cardiovascular Disease in CKD Stages 3 and 4: An Analysis From the Kidney Early Evaluation Program (KEEP)","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}